Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies, today announced ...

Black women are more likely than white women to die from even the most treatable types of breast cancer, a study published ...

Exposure-Response–Based Multiattribute Clinical Utility Score Framework to Facilitate Optimal Dose Selection for Oncology Drugs The Oncology Grand Rounds series is designed to place original reports ...

The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) ...

The surge in global cancer cases is raising serious concerns among experts. A recent study published in Monday in Cancer, a ...

In a new study, researchers found black women are at higher risk of dying from all tumor subtypes of breast cancer, with the ...

Breast cancer is the most diagnosed cancer among U.S. women and the second leading cause of cancer death. Black women who ...

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary ...

About Ignite Proteomics Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc., specializes in advanced RPPA technology for cancer diagnostics. As the only provider of a CLIA-accredited RPPA assay ...

The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now ...

Cannabis extract taken by the mouth could potentially provide additional relief for patients with chemotherapy-induced nausea ...

The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.